ELTX NASDAQ
Elicio Therapeutics, Inc.
1W: +4.3%
1M: -24.7%
3M: -41.8%
YTD: -76.2%
1Y: -82.5%
$1.92
+0.00 (+0.00%)
Weekly Expected Move ±8.3%
$2
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships6
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2023-01-17
Earliest Filing
2026-03-16
Latest Filing
partner: 3
investor: 1
target: 1
acquirer: 1
Counterparties (Filed by ELTX)
6 relationshipsCompanies named in ELTX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| JonesTrading Institutional Services LLC | — | partner | Sales agent for at-market offering program and terminated agreement | 2026-03-16 | View |
| Ladenburg Thalmann & Co. Inc. | — | partner | Sales agent for at-market offering program | 2026-03-16 | View |
| GKCC, LLC | — | investor | Purchased 1,213,000 shares of common stock in a private offering for approximately $7.0 million. | 2023-12-22 | View |
| NovaPark LLC | — | partner | Termination of lease agreement and redemption of 10% membership interest | 2023-03-14 | View |
| Elicio Therapeutics, Inc. | ELTX | target | Target company in a merger agreement with Angion Biomedica Corp. | 2023-01-17 | View |
| Arkham Merger Sub, Inc. | — | acquirer | Wholly owned subsidiary of Angion Biomedica Corp. used as the merger vehicle. | 2023-01-17 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-14 | Other Events | View | |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-07-02 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-06-24 | Regulation FD | View | |
| 2026-06-17 | Other Events | View | |
| 2026-06-15 | Other Events | View | |
| 2026-03-16 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement | Agreement | View |
| 2026-03-12 | Results of Operations and Financial Condition | View | |
| 2025-11-13 | Results of Operations and Financial Condition | View | |
| 2025-09-17 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-08-12 | Other Events | View | |
| 2025-08-07 | Results of Operations and Financial Condition | View | |
| 2025-08-05 | Other Events | View | |
| 2025-06-04 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-05-20 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-13 | Results of Operations and Financial Condition | View | |
| 2025-03-31 | Results of Operations and Financial Condition | View | |
| 2025-03-24 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-03-05 | Unregistered Sales of Equity Securities | View | |
| 2025-01-30 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR